HIV resurgence is feared as global funding to combat the disease falls 18%
admin Overall, government funding declined by more than $1.5 billion to $7.3 billion in 2025 —...
Health
Pharma’s drug spending deflection
To understand the current friction between the Pharmaceutical Research and Manufacturers of America (PhRMA) and...
FDA Panel Backs Peptide Compounding Amidst Record-Breaking Measles Outbreaks and Rising Foodborne Illness Concerns
The landscape of American public health is currently navigating a complex intersection of regulatory shifts,...
Pharmalot Coming and Going: Rigel Pharmaceuticals Taps Alison Hannah as New Chief Medical Officer.
The leadership carousel in the biotechnology sector continues to spin at a rapid clip, and...
There are already more U.S. measles cases this year than in all of 2025
The rapid escalation of cases in 2026 has officially made this the nation’s most severe...
FDA Advisory Panel Recommends Compounding Approval for Popular Peptides Amid Growing Political Tensions Over Scientific Oversight.
In a landmark two-day session that may signal a paradigm shift in American drug regulation,...
Real Food Is Vulnerable to Real Pathogens: Why the Cyclospora Outbreak Demands a Reevaluation of Food Safety Policy.
As the United States grapples with a record-breaking surge in foodborne illness, the intersection of...
Bipartisan Senate Push to Regulate Ultra-Processed Foods Gains Momentum Amid MAHA Movement Influence.
Amid intensifying national debates over whether the political influence of the "Make America Healthy Again"...
Merck Strikes Landmark Licensing Deals for Experimental Monthly HIV Prevention Pill to Expand Access in 129 Countries.
In a move that signals a significant shift in the global strategy to eradicate the...
FDA Advisory Panel Recommends Compounding for Popular Peptides Amidst Regulatory Tensions and Insulin Supply Hurdles.
In a landmark decision that signals a profound shift in the American regulatory landscape, an...
